338 related articles for article (PubMed ID: 12271353)
1. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery.
Sculean A; Windisch P; Keglevich T; Fabi B; Lundgren E; Lyngstadaas PS
Clin Oral Investig; 2002 Sep; 6(3):183-7. PubMed ID: 12271353
[TBL] [Abstract][Full Text] [Related]
2. Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting.
Cochran DL; Jones A; Heijl L; Mellonig JT; Schoolfield J; King GN
J Periodontol; 2003 Sep; 74(9):1269-81. PubMed ID: 14584859
[TBL] [Abstract][Full Text] [Related]
3. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
4. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of matrix molecules associated with wound healing following regenerative periodontal treatment in monkeys.
Sculean A; Junker R; Donos N; Berakdar M; Brecx M; Dünker N
Clin Oral Investig; 2002 Sep; 6(3):175-82. PubMed ID: 12271352
[TBL] [Abstract][Full Text] [Related]
6. Periodontal regeneration with enamel matrix derivative--case reports.
Manor A
J Int Acad Periodontol; 2000 Apr; 2(2):44-8. PubMed ID: 12666960
[TBL] [Abstract][Full Text] [Related]
7. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
8. Human histologic evaluation of an intrabony defect treated with enamel matrix derivative, xenograft, and GTR.
Sculean A; Windisch P; Chiantella GC
Int J Periodontics Restorative Dent; 2004 Aug; 24(4):326-33. PubMed ID: 15446402
[TBL] [Abstract][Full Text] [Related]
9. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
Sculean A; Schwarz F; Becker J; Brecx M
Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
[TBL] [Abstract][Full Text] [Related]
10. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
[TBL] [Abstract][Full Text] [Related]
11. Enamel matrix protein adsorption to root surfaces in the presence or absence of human blood.
Miron RJ; Bosshardt DD; Laugisch O; Katsaros C; Buser D; Sculean A
J Periodontol; 2012 Jul; 83(7):885-92. PubMed ID: 22122520
[TBL] [Abstract][Full Text] [Related]
12. Effect of enamel matrix proteins on the periodontal connective tissue-material interface after wound healing.
Craig RG; Kallur SP; Inoue M; Rosenberg PA; LeGeros RZ
J Biomed Mater Res A; 2004 Apr; 69(1):180-7. PubMed ID: 14999766
[TBL] [Abstract][Full Text] [Related]
13. The effects of EDTA gel conditioning exposure time on periodontitis-affected human root surfaces: surface topography and PDL cell adhesion.
Gamal AY; Mailhot JM
J Int Acad Periodontol; 2003 Jan; 5(1):11-22. PubMed ID: 12666951
[TBL] [Abstract][Full Text] [Related]
14. The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses.
Cochran DL; King GN; Schoolfield J; Velasquez-Plata D; Mellonig JT; Jones A
J Periodontol; 2003 Jul; 74(7):1043-55. PubMed ID: 12931768
[TBL] [Abstract][Full Text] [Related]
15. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain).
Sculean A; Chiantella GC; Windisch P; Donos N
Int J Periodontics Restorative Dent; 2000 Aug; 20(4):374-81. PubMed ID: 11203577
[TBL] [Abstract][Full Text] [Related]
17. A clinical study evaluating the treatment of supra-alveolar-type defects with access flap surgery with and without an enamel matrix protein derivative: a pilot study.
Jentsch H; Purschwitz R
J Clin Periodontol; 2008 Aug; 35(8):713-8. PubMed ID: 18631246
[TBL] [Abstract][Full Text] [Related]
18. Healing of fenestration-type defects following treatment with guided tissue regeneration or enamel matrix proteins. An experimental study in monkeys.
Sculean A; Donos N; Brecx M; Karring T; Reich E
Clin Oral Investig; 2000 Mar; 4(1):50-6. PubMed ID: 11218516
[TBL] [Abstract][Full Text] [Related]
19. Effects of enamel matrix proteins on tissue formation along the roots of human teeth.
Bosshardt DD; Sculean A; Windisch P; Pjetursson BE; Lang NP
J Periodontal Res; 2005 Apr; 40(2):158-67. PubMed ID: 15733151
[TBL] [Abstract][Full Text] [Related]
20. Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study.
Donos N; Sculean A; Glavind L; Reich E; Karring T
J Clin Periodontol; 2003 Dec; 30(12):1061-8. PubMed ID: 15002892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
